Markus Warmuth

1996–2025 年に発表

39
論文数
18,083
被引用数
36
h 指数
37
i10 指数

被引用数

Markus Warmuth の年別被引用数1948 年: 被引用 1 件1988 年: 被引用 1 件1991 年: 被引用 1 件1997 年: 被引用 1 件1998 年: 被引用 2 件1999 年: 被引用 2 件2000 年: 被引用 6 件2001 年: 被引用 1 件2002 年: 被引用 14 件2003 年: 被引用 17 件2004 年: 被引用 24 件2005 年: 被引用 25 件2006 年: 被引用 35 件2007 年: 被引用 44 件2008 年: 被引用 70 件2009 年: 被引用 63 件2010 年: 被引用 95 件2011 年: 被引用 107 件2012 年: 被引用 160 件2013 年: 被引用 223 件2014 年: 被引用 259 件2015 年: 被引用 305 件2016 年: 被引用 324 件2017 年: 被引用 303 件2018 年: 被引用 358 件2019 年: 被引用 900 件2020 年: 被引用 913 件2021 年: 被引用 898 件2022 年: 被引用 667 件2023 年: 被引用 477 件2024 年: 被引用 699 件2025 年: 被引用 331 件2026 年: 被引用 35 件1949〜1987 年は被引用が無いため表示していません1989〜1990 年は被引用が無いため表示していません1992〜1996 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,529 件、この内訳の 32.7%中国: 引用元論文 1,426 件、この内訳の 13.2%ドイツ: 引用元論文 625 件、この内訳の 5.8%イギリス: 引用元論文 622 件、この内訳の 5.8%イタリア: 引用元論文 402 件、この内訳の 3.7%カナダ: 引用元論文 343 件、この内訳の 3.2%フランス: 引用元論文 331 件、この内訳の 3.1%スイス: 引用元論文 315 件、この内訳の 2.9%日本: 引用元論文 309 件、この内訳の 2.8%スペイン: 引用元論文 240 件、この内訳の 2.2%オーストラリア: 引用元論文 224 件、この内訳の 2.1%オランダ: 引用元論文 215 件、この内訳の 2%
0%32.7%その他 20.5%

分野

  • Biochemistry, Genetics and Molecular Biology51.8%
  • Medicine32.4%
  • Computer Science9.4%
  • Immunology and Microbiology1.8%
  • Chemistry1.2%
  • Neuroscience0.7%
  • その他2.7%

トピック

  • Computational Drug Discovery Methods4.4%
  • Bioinformatics and Genomic Networks3.3%
  • Cancer Genomics and Diagnostics3.2%
  • RNA modifications and cancer3%
  • Epigenetics and DNA Methylation2.7%
  • RNA Research and Splicing2.3%
  • その他81.1%

共著者

全論文

検索で開く
  1. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kalpana Jagtap, Michael D. Jones, Li Wang, Charlie Hatton, Emanuele Palescandolo, Supriya Gupta, Scott Mahan, Carrie Sougnez, Robert C. Onofrio, Ted Liefeld, Laura E. MacConaill, Wendy Winckler, Michael Reich, Nanxin Li, Jill P. Mesirov, Stacey Gabriel, Gad Getz, Kristin Ardlie, Vivien W. Chan, Vic E. Myer, Barbara L. Weber, Jeff Porter, Markus Warmuth, Peter M. Finan, Jennifer L. Harris, Matthew Meyerson, Todd R. Golub, Michael Morrissey, William R. Sellers, Robert Schlegel, Levi A. Garraway - Nature 2012 被引用: 8,599

  2. Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dyuti Majumdar, Matthew J. Meyer, Mark Palermo, Lawrence Perez, Minying Pu, Edmund V. Price, Christopher Quinn, Subarna Shakya, Michael D. Shultz, Joanna Slisz, K. Venkatesan, Ping Wang, Markus Warmuth, Sarah Williams, Guizhi Yang, Jing Yuan, Ji-Hu Zhang, Ping Zhu, Timothy M. Ramsey, Nicholas Keen, William R. Sellers, Travis Stams, Pascal D. Fortin - Nature 2016 被引用: 946

  3. Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Medicinal Chemistry 2018 被引用: 447

  4. The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2017 被引用: 614

  5. H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Huilan Yao, Lihua Yu, Ping Zhu, Omar Abdel‐Wahab, Peter G. Smith, Silvia Buonamici - Nature Medicine 2018 被引用: 510

  6. Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3′ Splice Site Selection through Use of a Different Branch Point

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ping Zhu, Guillermo Garcia‐Manero, Richard R. Furman, Lihua Yu, Peter G. Smith, Silvia Buonamici - Cell Reports 2015 被引用: 463

  7. Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2010 被引用: 606

  8. H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter G. Smith, Anand Selvaraj - Cancer Research 2017 被引用: 151

  9. Loss of function JAK1 mutations occur at high frequency in cancers with microsatellite instability and are suggestive of immune evasion

    著者: , , , , , , , - PLoS ONE 2017 被引用: 137

  10. Mining the CRBN target space redefines rules for molecular glue–induced neosubstrate recognition

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xavier Lucas, Elisa Liardo, Nina Ilic Widlund, Andreas Ritzén, Ramon Miguel Caceres, Dominico Vigil, Jennifer Tsai, Owen B. Wallace, Marisa Peluso, Amine Sadok, Ralph Tiedt, Alison M. Paterson, Vladislav Zarayskiy, Bernhard Fasching, Débora Bonenfant, Markus Warmuth, John C. Castle, Sharon A. Townson - Science 2025 被引用: 71

  11. Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter C. Black, Peter Fekkes, Peter G. Smith, Markus Warmuth, Lihua Yu, Ming‐Hong Hao, Nicholas Larsen, Mads Daugaard, Ping Zhu - Nature Communications 2017 被引用: 145

  12. Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2010 被引用: 554

  13. Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A–SF3b complex

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2017 被引用: 149

  14. Synthesis, Structure–Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) Currently in Phase 1 and Phase 2 Clinical Trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Todd Groessl, You-Qun He, Andrew Phimister, J. Alex Aycinena, Christian C. Lee, Badry Bursulaya, Donald S. Karanewsky, H. Martin Seidel, Jennifer L. Harris, Pierre‐Yves Michellys - Journal of Medicinal Chemistry 2013 被引用: 412

  15. Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK

    著者: , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 被引用: 377

  16. Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - ACS Medicinal Chemistry Letters 2010 被引用: 328

  17. Ba/F3 cells and their use in kinase drug discovery

    著者: , , , , - Current Opinion in Oncology 2006 被引用: 242

  18. Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John D. Norris, Morgan O’Shea, Sunil Pancholi, Sudeep Prajapati, Sujatha Rajagopalan, Dominic J. Reynolds, Victoria Rimkunas, Nathalie Rioux, Ricardo Ribas, Amy Siu, Sasirekha Sivakumar, Vanitha Subramanian, Michaël Thomas, Frédéric H. Vaillancourt, John Wang, Suzanne E. Wardell, Michael J. Wick, Shihua Yao, Lihua Yu, Markus Warmuth, Peter G. Smith, Ping Zhu, Manav Korpal - Cancer Discovery 2018 被引用: 112

  19. Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kalpana Jagtap, Michael D. Jones, Li Wang, Charlie Hatton, Emanuele Palescandolo, Supriya Gupta, Scott Mahan, Carrie Sougnez, Robert C. Onofrio, Ted Liefeld, Laura E. MacConaill, Wendy Winckler, Michael Reich, Nanxin Li, Jill P. Mesirov, Stacey Gabriel, Gad Getz, Kristin Ardlie, Vivien W. Chan, Vic E. Myer, Barbara L. Weber, Jeff Porter, Markus Warmuth, Peter M. Finan, Jennifer L. Harris, Matthew Meyerson, Todd R. Golub, Michael Morrissey, William R. Sellers, Robert Schlegel, Levi A. Garraway - Nature 2012 被引用: 112

  20. Mining the CRBN Target Space Redefines Rules for Molecular Glue-induced Neosubstrate Recognition

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nina Ilic Widlund, Andreas Ritzén, Ramon Miguel Caceres, Dominico Vigil, Jennifer J. Tsai, Owen B. Wallace, Marisa O. Peluso, Amine Sadok, Alison M. Paterson, Vladislav Zarayskiy, Bernhard Fasching, Débora Bonenfant, Markus Warmuth, John Castle, Sharon A. Townson - 2024 被引用: 18

  21. NAMPT Is the Cellular Target of STF-31-Like Small-Molecule Probes

    著者: , , , , , , , , , , , - ACS Chemical Biology 2014 被引用: 79

  22. Expansion of Bcr-Abl-Positive Leukemic Stem Cells Is Dependent on Hedgehog Pathway Activation

    著者: , , , , , , , , , , - Cancer Cell 2008 被引用: 512

  23. Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2010 被引用: 253

  24. Essential role of stromally induced hedgehog signaling in B-cell malignancies

    著者: , , , , , , , , , , , - Nature Medicine 2007 被引用: 321